About Mellitus
Mellitus is a company based in Boston (United States) founded in 2011.. Mellitus has raised $16.1 million across 10 funding rounds. Mellitus offers products and services including Pengeluaran Cambodia, Live Draw Cambodia, Keluaran Kamboja, and Tabel Data Kamboja. Mellitus operates in a competitive market with competitors including Viome Life Sciences, Proteomics International, Tethys BioScience, SmartZyme and Veralight, among others.
- Headquarter Boston, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$16.1 M (USD)
in 10 rounds
-
Latest Funding Round
$2.8 M (USD), Series A
May 07, 2019
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Mellitus
Mellitus offers a comprehensive portfolio of products and services, including Pengeluaran Cambodia, Live Draw Cambodia, Keluaran Kamboja, and Tabel Data Kamboja. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides official Cambodian lottery results for betting analysis.
Offers real-time draws for accurate lottery outcomes.
Delivers daily lottery output for user predictions.
Compiles historical data for lottery trend analysis.
Unlock access to complete
Unlock access to complete
Funding Insights of Mellitus
Mellitus has successfully raised a total of $16.1M across 10 strategic funding rounds. The most recent funding activity was a Series A round of $2.8 million completed in May 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Series A — $2.8M
-
First Round
First Round
(02 Oct 2013)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2019 | Amount | Series A - Mellitus | Valuation |
investors |
|
| Sep, 2018 | Amount | Series A - Mellitus | Valuation |
investors |
|
| Jul, 2018 | Amount | Series A - Mellitus | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Mellitus
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Mellitus
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Mellitus Comparisons
Competitors of Mellitus
Mellitus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viome Life Sciences, Proteomics International, Tethys BioScience, SmartZyme and Veralight, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of tests to prevent, treat, and cure chronic diseases, and cancer
|
|
| domain | founded_year | HQ Location |
Medical technology company at the forefront of predictive diagnostics and bio-analytical services
|
|
| domain | founded_year | HQ Location |
Develops biological markers for medical diagnostic applications.
|
|
| domain | founded_year | HQ Location |
Proprietary protein engineering technology is developed for diabetes products.
|
|
| domain | founded_year | HQ Location |
Offers biomarker screening solutions for early diabetes detection.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Mellitus
When was Mellitus founded?
Mellitus was founded in 2011 and raised its 1st funding round 2 years after it was founded.
Where is Mellitus located?
Mellitus is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Is Mellitus a funded company?
Mellitus is a funded company, having raised a total of $16.1M across 10 funding rounds to date. The company's 1st funding round was a Series A of $1.75M, raised on Oct 02, 2013.
What does Mellitus do?
Mellitus was founded in 2011 in Boston, United States, within the biotechnology sector. An in vitro diagnostic assay for diabetes is being developed, drawing on technology licensed from Harvard University. The lead candidate measures the Glycated CD59 biomarker and targets screening, diagnosis, and monitoring of Gestational Diabetes Mellitus. Applications as a companion diagnostic for pharmaceutical development are also pursued.
Who are the top competitors of Mellitus?
Mellitus's top competitors include Viome Life Sciences, Proteomics International and SmartZyme.
What products or services does Mellitus offer?
Mellitus offers Pengeluaran Cambodia, Live Draw Cambodia, Keluaran Kamboja, and Tabel Data Kamboja.